Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: Relationship with aberrant promoter methylation of the CDKN2A and RARB genes

Cancer Genetics and Cytogenetics

Volumn 162, Issue 1, 2005, Pages 10-20

  Chan, Eunice C ^a   Lam, Shui Y ^b   Fu, Kin H ^c   Kwong, Yok L ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b KOWLOON HOSPITAL   (Hong Kong)

^c TSEUNG KWAN O HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DEATH ASSOCIATED PROTEIN KINASE; ENZYME; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; METHYLGUANINE DNA METHYLTRANSFERASE; MYELOPEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE QUININE OXIDOREDUCTASE; RETINOIC ACID RECEPTOR BETA; UNCLASSIFIED DRUG; X RAY REPAIR CROSS COMPLEMENTING GROUP 1;

ADULT; ALLELE; ARTICLE; CANCER RISK; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; GENES, P16; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; INTERLEUKIN-3; ISOENZYMES; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, RETINOIC ACID; RECOMBINANT FUSION PROTEINS;

ALIAS; CINCHONA PUBESCENS;

EID: 24644442180     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.03.008     Document Type: Article

References (61)

1. R.T. Greenlee, M.B. Hill-Harmon, T. Murray, and M. Thun Cancer statistics, 2001 CA Cancer J Clin 51 2001 15 36
2. Y.C. Hu, D. Sidransky, and S.A. Ahrendt Molecular detection approaches for smoking associated tumors Oncogene 21 2002 7289 7297
3. D.A. Bell, J.A. Taylor, D.F. Pulson, C.N. Robertson, J.L. Mohler, and G.W. Lucier Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increase susceptibility in bladder cancer J Natl Cancer Inst 85 1993 1159 1164
4. J. To-Figueras, M. Gene, J. Gomez-Catalan, M.C. Galan, M. Fuentes, J.M. Ramon, M. Rodamilans, E. Huguet, and J. Corbella Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among northwestern Mediterraneans Carcinogenesis 18 1997 1529 1533
5. N. Jourenkova-Mironova, H. Wikman, C. Bouchardy, A. Voho, P. Dayer, S. Benhamou, and A. Hirvonen Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer Pharmacogenetics 8 1998 495 502
6. Y. Gao, and Q. Zhang Polymorphisms of the GSTM1 and CYP2D6 genes associated with susceptibility to lung cancer in Chinese Mutat Res 444 1999 441 449
7. S.J. London, J.M. Yuan, F.L. Chung, Y.T. Gao, G.A. Coetzee, R.K. Ross, and M.C. Yu Isothiocyanates, glutathione S transferase M1 and T1 polymorphisms, and lung cancer risk: a prospective study of men in Shanghai, China Lancet 356 2000 724 729
8. A. Risch, H. Wikman, S. Thiel, P. Schmezer, L. Edler, P. Driings, H. Dienemann, K. Kayser, V. Schulz, B. Spiegelhalder, and H. Bartsch Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to nonsmall cell lung cancer subtypes and hamartomas Pharmacogenetics 11 2001 757 764
9. B. Zhao, A. Seow, E.J. Lee, W.T. Poh, M. Teh, P. Eng, Y.T. Wang, W.C. Tan, M.C. Yu, and H.P. Lee Dietary isothiocyanates, glutathione S-transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore Cancer Epidemiol Biomarkers Prev 10 2001 1063 1067
10. S. Chen, K. Xue, L. Xu, G. Ma, and J. Wu Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population Mutat Res 458 2001 41 47
11. I. Stucker, A. Hirvonen, I. de Waziers, A. Cabelguenne, K. Mitrunen, S. Cenee, E. Koum-Besson, D. Hemon, P. Beaune, and M.A. Loriot Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility Carcinogenesis 23 2002 1475 1481
12. S. Benhamou, W.J. Lee, A.K. Alexandrie, P. Boffetta, C. Bouchardy, D. Butkiewicz, J. Brockmoller, M.L. Clapper, A. Daly, V. Dolzan, J. Ford, L. Gaspari, A. Haugen, A. Hirvonen, K. Husgafvel-Pursiainen, M. Ingelman-Sundberg, I. Kalina, M. Kihara, P. Kremers, L. Le Marchand, S.J. London, V. Nazar-Stewart, M. Onon-Kihara, A. Rannug, M. Romkes, D. Ryberg, J. Seidegard, P. Shields, R.C. Strange, I. Stucker, J. To-Figueras, P. Brennan, and E. Taioli Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk Carcinogenesis 23 2002 1343 1350
13. S.J. London, T.A. Lehman, and J.A. Taylor Myeloperoxidase genetic polymorphism and lung cancer risk Cancer Res 57 1997 5001 5003
14. I. Cascorbi, S. Henning, J. Brockmoller, J. Gephart, C. Meisel, J.M. Muller, R. Loddenkemper, and I. Roots Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant-463A of the myeloperoxidase gene Cancer Res 60 2000 644 649
15. L. Le Marchand, A. Seifried, A. Lum, and L.R. Wilkens Association of the myeloperoxidase -463G→A polymorphism with lung cancer risk Cancer Epidemiol Biomarkers Prev 9 2000 181 184
16. A. Feyler, A. Voho, C. Bouchardy, K. Kuokkanen, P. Dayer, A. Hirvonen, and S. Benhamou Myeloperoxidase -463G→A polymorphism and lung cancer risk. Point/Counterpoint: Point Cancer Epidemiol Biomarkers Prev 11 2002 1550 1554
17. L.L. Xu, G. Liu, D.P. Miller, W. Zhou, T.J. Lynch, J.C. Wain, L. Su, and D.C. Christiani The myeloperoxidase -463G→A polymorphism does not decrease lung cancer susceptibility in Caucasians. Point/Counterpoint: Counterpoint Cancer Epidemiol Biomarkers Prev 11 2002 1555 1559
18. W. Lu, D. Xing, J. Qi, W. Tan, X. Miao, and D. Lin Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population Int J Cancer 102 2002 275 279
19. E.M. Sturgis, E.J. Castillo, L. Li, R. Zheng, S.A. Eicher, G.L. Clayman, S.S. Strom, M.R. Spitz, and Q. Wei Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck Carcinogenesis 20 1999 2125 2129
20. E.L. Goode, C.M. Ulrich, and J.D. Potter Polymorphisms in DNA repair genes and associations with cancer risk Cancer Epidemiol Biomarkers Prev 11 2002 1513 1530
21. S. Chen, D. Tang, K. Xue, L. Xu, G. Ma, Y. Hsu, and S.S. Cho DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population Carcinogenesis 23 2002 1321 1325
22. H. Chen, A. Lum, A. Seifried, L.R. Wilkens, and L. Le Marchand Association of the NAD(P)H:quinone oxidoreductase 609C→T polymorphism with a decreased lung cancer risk Cancer Res 59 1999 3045 3048
23. N. Sunaga, T. Kohno, N. Yanagitani, H. Sugimura, H. Kunitoh, T. Tamura, Y. Takei, S. Tsuchiya, R. Saito, and J. Yokota Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility Cancer Epidemiol Biomarkers Prev 11 2002 730 738
24. S.B. Baylin, J.G. Herman, J.R. Graff, P.M. Vertino, and J.P. Issa Alterations in DNA methylation: a fundamental aspect of neoplasia Adv Cancer Res 72 1998 141 196
25. S.A. Belinsky, K.J. Nikula, W.A. Palmisano, R. Michels, G. Saccomanno, E. Gabrielson, S.B. Baylin, and J.G. Herman Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis Proc Natl Acad Sci U S A 95 1998 11891 11896
26. A.K. Virmani, A. Rathi, S. Zochbauer-Muller, N. Sacchi, Y. Fukuyama, D. Bryant, A. Maitra, S. Heda, K.M. Fong, F. Thunnissen, J.D. Minna, and A.F. Gazdar Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas J Natl Cancer Inst 92 2000 1303 1307
27. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia Cancer Res 59 1999 793 797
28. X. Tang, F.R. Khuri, J.J. Lee, B.L. Kemp, D. Liu, W.K. Hong, and L. Mao Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer J Natl Cancer Inst 92 2000 1511 1516
29. D.G. Burbee, E. Forgacs, S. Zochbauer-Muller, L. Shivakumar, K. Fong, B. Gao, D. Randle, M. Kondo, A. Virmani, S. Bader, Y. Sekido, F. Latif, S. Milchgrub, S. Toyooka, A.F. Gazdar, M.I. Lerman, E. Zabarovsky, M. White, and J.D. Minna Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression J Natl Cancer Inst 93 2001 691 699
30. H. Usadel, J. Brabender, K.D. Danenberg, C. Jeronimo, S. Harden, J. Engles, P.V. Danenberg, S. Yang, and D. Sidransky Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer Cancer Res 62 2002 371 375
31. Y.C. Wang, Y.P. Lu, R.C. Tseng, R.K. Lin, J.W. Chang, J.T. Chen, C.M. Shih, and C.Y. Chen Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples J Clin Invest 111 2003 887 895
32. S. Zochbauer-Muller, K.M. Fong, A.K. Virmani, J. Geradts, A.F. Gazdar, and J.D. Minna Aberrant promoter methylation of multiple genes in non-small cell lung cancers Cancer Res 61 2001 249 255
33. I.I. Wistuba, S. Lam, C. Behrens, A.K. Virmani, K.M. Fong, J. LeRiche, J.M. Samet, S. Srivastava, J.D. Minna, and A.F. Gazdar Molecular damage in the bronchial epithelium of current and former smokers J Natl Cancer Inst 89 1997 1366 1373
34. M. Kersting, C. Friedl, A. Kraus, M. Behn, W. Pankow, and M. Schuermann Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers J Clin Oncol 18 2000 3221 3229
35. W.A. Palmisano, K.K. Divine, G. Saccomanno, F.D. Gilliland, S.B. Baylin, J.G. Herman, and S.A. Belinsky Predicting lung cancer by detecting aberrant promoter methylation in sputum Cancer Res 60 2000 5954 5958
36. J.C. Soria, M. Rodriguez, D.D. Liu, J.J. Lee, W.K. Hong, and L. Mao Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers Cancer 62 2002 351 355
37. S.A. Belinsky, W.A. Palmisano, F.D. Gilliland, L.A. Crooks, K.K. Divine, S.A. Winters, M.J. Grimes, H.J. Harms, C.S. Tellez, T.M. Smith, P.P. Moots, J.F. Lechner, C.A. Stidley, and R.E. Crowell Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers Cancer Res 62 2002 2370 2377
38. S. Honorio, A. Agathanggelou, M. Schuermann, W. Pankow, P. Viacava, E.R. Maher, and F. Latif Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients Oncogene 22 2003 147 150
39. E.C. Chan, S.Y. Lam, K.W. Tsang, B. Lam, J.C.M. Ho, K.H. Fu, W.K. Lam, and Y.L. Kwong Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalveolar lavage Clin Cancer Res 8 2002 3741 3746
40. 6-methylguanine-DNA methyltransferase in sputum Cancer Res 62 2002 2248 2252
41. R.S. Houlston Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis Cancer Epidemiol Biomarkers Prev 8 1999 675 682
42. M.R. Shen, I.M. Jones, and H. Mohrenweiser Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans Cancer Res 58 1998 604 608
43. J.D. Hayes, and R.C. Strange Glutathione S-transferase polymorphisms and their biological consequences Pharmacology 61 2000 154 166
44. D. Ryberg, A. Hewer, D.H. Philips, and A. Haugen Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients Cancer Res 54 1994 5801 5803
45. A.K. Alexandrie, M.I. Sundberg, J. Seidegard, G. Tornling, and A. Rannug Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age of onset, gender and histological cancer types Carcinogenesis 15 1994 1785 1790
46. Y. Sekido, K.M. Fong, and J.D. Minna Molecular genetics of lung cancer Annu Rev Med 54 2003 73 87
47. A.F. Gazdar, and J.D. Minna Cigarettes, sex, and lung adenocarcinoma J Natl Cancer Inst 89 1997 1563 1565
48. X.C. Xu, G. Sozzi, J.S. Lee, J.J. Lee, U. Pastorino, S. Pilotti, J.M. Kurie, W.K. Hong, and R. Lotan Suppression of retinoic acid receptor β in non-small-cell lung cancer in vivo: implications for lung cancer development J Natl Cancer Inst 89 1997 624 629
49. F.J. Piedrafita, R.B. Molander, G. Vansant, E.A. Orlova, M. Pfahl, and W.F. Reynolds An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element J Biol Chem 271 1996 14412 14420
50. L.H. Thompson, K.W. Brookman, N.J. Jones, S.A. Allen, and A.V. Carrano Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange Mol Cell Biol 10 1990 6160 6171
51. D. Ratnasinghe, S.X. Yao, J.A. Tangrea, Y.L. Qiao, M.R. Andersen, M.J. Barrett, C.A. Giffen, Y. Erozan, M.S. Tockman, and P.R. Taylor Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk Cancer Epidemiol Biomarkers Prev 10 2001 119 123
52. D. Butkiewicz, M. Rusin, L. Enewold, P.G. Shields, M. Chorazy, and C.C. Harris Genetic polymorphisms in DNA repair genes and risk of lung cancer Carcinogenesis 22 2001 593 597
53. G.L. David-Beabes, and S.J. London Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians Lung Cancer 34 2001 333 339
54. P. Lin, Y.M. Hsueh, J.L. Ko, Y.F. Liang, K.J. Tsai, and C.Y. Chen Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan Lung Cancer 40 2003 123 129
55. D.P. Miller, I. De Vivo, D. Neuberg, J.C. Wain, T.J. Lynch, L. Su, and D.C. Christiani Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism Int J Cancer 104 2003 758 763
56. F.P. Perera, L.A. Mooney, M. Stampfer, D.H. Phillips, D.A. Bell, A. Rundle, S. Cho, W.Y. Tsai, J. Ma, A. Blackwood, and D. Tang Physicians' Health Cohort Study. Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study Carcinogenesis 23 2002 1641 1646
57. D.P. Miller, G. Liu, I. De Vivo, T.J. Lynch, J.C. Wain, L. Su, and D.C. Christiani Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk Cancer Res 62 2002 2819 2823
58. M.J. Harris, M. Coggan, L. Langton, S.R. Wilson, and P.G. Board Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients Pharmacogenetics 8 1998 27 31
59. S.J. Lewis, N.M. Cherry, R.M. Niven, P.V. Barber, and A.C. Povey GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risks Cancer Lett 180 2002 165 171
60. E.A. Zang, and E.L. Wynder Differences in lung cancer risk between men and women: examination of the evidence J Natl Cancer Inst 88 1996 183 192
61. M. Chan-Yeung, L.C. Koo, J.C.M. Ho, K.W.T. Tsang, W.S. Chau, S.W. Chiu, M.S.M. Ip, and W.K. Lam Risk factors associated with lung cancer in Hong Kong Lung cancer 40 2003 131 140